136 related articles for article (PubMed ID: 8341767)
1. Effects of single dose haloperidol administration on plasma homovanillic acid levels in normal subjects.
Magliozzi JR; Doran AR; Gietzen DW; Olson AM; Maclin EL; Tuason VB
Psychiatry Res; 1993 May; 47(2):141-9. PubMed ID: 8341767
[TBL] [Abstract][Full Text] [Related]
2. Evolution of plasma homovanillic acid (HVA) in chronic schizophrenic patients treated with haloperidol.
Galinowski A; Poirier MF; Aymard N; Leyris A; Beauverie P; Bourdel MC; Loo H
Acta Psychiatr Scand; 1998 Jun; 97(6):458-66. PubMed ID: 9669519
[TBL] [Abstract][Full Text] [Related]
3. Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations.
Davidson M; Kahn RS; Knott P; Kaminsky R; Cooper M; DuMont K; Apter S; Davis KL
Arch Gen Psychiatry; 1991 Oct; 48(10):910-3. PubMed ID: 1929760
[TBL] [Abstract][Full Text] [Related]
4. Dopamine turnover in schizophrenia before and after haloperidol withdrawal. CSF, plasma, and urine studies.
Beuger M; van Kammen DP; Kelley ME; Yao J
Neuropsychopharmacology; 1996 Jul; 15(1):75-86. PubMed ID: 8797194
[TBL] [Abstract][Full Text] [Related]
5. Circadian variation of plasma homovanillic acid levels is attenuated by fluphenazine in patients with schizophrenia.
Doran AR; Labarca R; Wolkowitz OM; Roy A; Douillet P; Pickar D
Arch Gen Psychiatry; 1990 Jun; 47(6):558-63. PubMed ID: 2350208
[TBL] [Abstract][Full Text] [Related]
6. Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics.
Duncan E; Wolkin A; Angrist B; Sanfilipo M; Wieland S; Cooper TB; Rotrosen J
Biol Psychiatry; 1993 Oct; 34(8):523-8. PubMed ID: 8274579
[TBL] [Abstract][Full Text] [Related]
7. Acute effects of neuroleptics on unmedicated schizophrenic patients and controls.
Miller AL; Maas JW; Contreras S; Seleshi E; True JE; Bowden C; Castiglioni J
Biol Psychiatry; 1993 Aug; 34(3):178-87. PubMed ID: 8104509
[TBL] [Abstract][Full Text] [Related]
8. Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics.
Kim YK; Kim L; Lee MS
Schizophr Res; 2000 Sep; 44(3):165-75. PubMed ID: 10962218
[TBL] [Abstract][Full Text] [Related]
9. Persistence of cyclicity of the plasma dopamine metabolite, homovanillic acid, in neuroleptic treated schizophrenic patients.
Davila R; Zumarraga M; Andia I; Friedhoff AJ
Life Sci; 1989; 44(16):1117-21. PubMed ID: 2565009
[TBL] [Abstract][Full Text] [Related]
10. Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment.
Kahn RS; Davidson M; Knott P; Stern RG; Apter S; Davis KL
Arch Gen Psychiatry; 1993 Aug; 50(8):599-605. PubMed ID: 7688208
[TBL] [Abstract][Full Text] [Related]
11. Short-term haloperidol administration acutely elevates human plasma homovanillic acid concentration.
Davidson M; Giordani AB; Mohs RC; Horvath TB; Davis BM; Powchik P; Davis KL
Arch Gen Psychiatry; 1987 Feb; 44(2):189-90. PubMed ID: 3813816
[No Abstract] [Full Text] [Related]
12. Acute and chronic effects of neuroleptic drugs on plasma and brain homovanillic acid in the rat.
Kendler KS; Davis KL
Psychiatry Res; 1984 Sep; 13(1):51-8. PubMed ID: 6151204
[TBL] [Abstract][Full Text] [Related]
13. Studies of catecholamine metabolism in schizophrenia/psychosis--II.
Maas JW; Contreras SA; Miller AL; Berman N; Bowden CL; Javors MA; Seleshi E; Weintraub SE
Neuropsychopharmacology; 1993 Feb; 8(2):111-6. PubMed ID: 8471122
[TBL] [Abstract][Full Text] [Related]
14. Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.
Davidson M; Kahn RS; Powchik P; Warne P; Losonczy MF; Kaminsky R; Apter S; Jaff S; Davis KL
Arch Gen Psychiatry; 1991 Jan; 48(1):73-6. PubMed ID: 1670618
[TBL] [Abstract][Full Text] [Related]
15. Interrelationships between plasma homovanillic acid and indices of dopamine turnover in multiple brain areas during haloperidol and saline administration.
Csernansky JG; Barnes DE; Bellows EP; Lombrozo L
Life Sci; 1990; 46(10):707-13. PubMed ID: 2314192
[TBL] [Abstract][Full Text] [Related]
16. Effects of debrisoquin and haloperidol on plasma homovanillic acid concentration in schizophrenic patients.
Davidson M; Losonczy MF; Mohs RC; Lesser JC; Powchik P; Freed LB; Davis BM; Mykytyn VV; Davis KL
Neuropsychopharmacology; 1987 Dec; 1(1):17-23. PubMed ID: 3509064
[TBL] [Abstract][Full Text] [Related]
17. Plasma homovanillic acid as an index of brain dopamine metabolism: enhancement with debrisoquin.
Sternberg DE; Heninger GR; Roth RH
Life Sci; 1983 May; 32(21):2447-52. PubMed ID: 6855448
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of haloperidol on negative symptoms in drug-naive schizophrenic patients: effects on plasma homovanillic acid.
Labarca R; Silva H; Jerez S; Ruiz A; Forray MI; Gysling K; Andres ME; Bustos G; Castillo Y; Hono J
Schizophr Res; 1993 Mar; 9(1):29-34. PubMed ID: 8461269
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment plasma HVA predicts neuroleptic response in manic psychosis.
Mazure CM; Bowers MB
J Affect Disord; 1998 Feb; 48(1):83-6. PubMed ID: 9495606
[TBL] [Abstract][Full Text] [Related]
20. Plasma homovanillic acid levels and subtyping of schizophrenia.
Chang WH; Chen TY; Lee CF; Hung JC; Hu WH; Yeh EK
Psychiatry Res; 1988 Mar; 23(3):239-44. PubMed ID: 3387499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
